Study Name: Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
26 locations found
- GSK Investigational Site
Location: Greenbrae, California 94904
- GSK Investigational Site
Location: Monterey, California 93940
- GSK Investigational Site
Location: Pleasant Hill, California 94523
- GSK Investigational Site
Location: Rancho Mirage, California 92270
- GSK Investigational Site
Location: San Diego, California 92123
- GSK Investigational Site
Location: Pembroke Pines, Florida 33028
- GSK Investigational Site
Location: Port St. Lucie, Florida 34952
- GSK Investigational Site
Location: West Palm Beach, Florida 33401
- GSK Investigational Site
Location: Macon, Georgia 31201
- GSK Investigational Site
Location: Marietta, Georgia 30060
- GSK Investigational Site
Location: Peoria, Illinois 61615
- GSK Investigational Site
Location: Skokie, Illinois 60076
- GSK Investigational Site
Location: Indianapolis, Indiana 46237
- GSK Investigational Site
Location: Shreveport, Louisiana 71103
- GSK Investigational Site
Location: Columbia, Missouri 65201
- GSK Investigational Site
Location: Kansas City, Missouri 64111
- GSK Investigational Site
Location: Springfield, Missouri 65807
- GSK Investigational Site
Location: Lincoln, Nebraska 68506
- GSK Investigational Site
Location: Lincoln, Nebraska 68510
- GSK Investigational Site
Location: Lake Success, New York 11042
- GSK Investigational Site
Location: Greensboro, North Carolina 27403
- GSK Investigational Site
Location: Hazleton, Pennsylvania 18201
- GSK Investigational Site
Location: Willow Grove, Pennsylvania 19090
- GSK Investigational Site
Location: Fort Sam Houston, Texas 78234
- GSK Investigational Site
Location: Salt Lake City, Utah 84106
- GSK Investigational Site
Location: Spokane, Washington 99208
|